Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among U.S. patient groups who reported working with, or who were familiar with the company.
The new program and website are designed to create conversations that will lead to new resources to support diversity, equity, inclusion and allyship within the rare disease community . | February 28, 2022
(0)
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked #1 in overall corporate reputation among U.S. patient groups that reported working with the company, and #2 in overall corporate reputation among U.S. patient groups familiar with the company. These results are based on PatientView s annual survey of 207 U.S. patient groups who evaluated 38 pharmaceutical and biotechnology companies. Every day our patient advocacy team is working with patient groups to support their efforts toward improving the lives of people living with some of the most challenging diseases, said Matt Flesch, vice president, patient advocacy and communications, Horizon. To be recognized by these patient groups who we have learned so much from and whose insights have guided nearly every facet of our work is an honor. We are humbled by the feedback provided within the PatientView report and look forward to continued opportunities to support the transformative work led by patient advocacy
(0) In its inaugural year on the survey, Horizon had top rankings in integrity, patient information and services among patient groups partnering with the company
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked #4 in overall corporate reputation among nearly 50 pharmaceutical and biotech companies based on PatientView s annual survey of 1,920 patient groups worldwide. We are incredibly grateful to work with patient groups who share our commitment to improving the lives of people living with rare, autoimmune and severe inflammatory diseases, said Tim Walbert, chairman, president and chief executive officer, Horizon. At Horizon, our patient advocacy team works diligently to listen, learn and partner with patient groups in order to incorporate those critical voices and experiences into everything we do. We re humbled by these results and thank all of the patient organizations who shared their perspectives.
Horizon Therapeutics plc Shines a Light on Rare Disease with the Launch of the #RAREis Photobooth to Benefit Make-A-Wish financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.